Amby is a leading strategic talent partner to some of the most innovative companies in the world, enabling their business growth through a proven combination of recruitment infrastructure, operations, and data. We are committed to transforming industries through people and creating a more sustainable future for companies and talent. With over 10 years of experience, we provide the power to scale faster by issuing access to global best talent practices, insight, strategies, tools, and systems, as well as a certified team of recruitment, HR, and marketing professionals dedicated to delivering quality results aligned with your business targets and aspirations.

Klu is a powerful search and data retrieval platform that integrates with popular cloud-based applications. It enables users to search, access, and utilize their data quickly and efficiently. We believe in the power of AI and advanced technologies to transform the way people interact with their data. 💪 We believe in the power of information Our mission at Klu is to revolutionize the way people find and share digital information. We strive to make it easy and effortless to search for any type of information, and to provide relevant and accurate results. The goal is to make Klu an indispensable tool for anyone who relies on digital information to do their job. 🚀 Innovation We are committed to continuously improving and expanding our technology to provide the best possible search experience for our users. We strive to make it easy and effortless for users to find the information they need, and to provide relevant and accurate results. 🙌 Collaboration We believe that sharing information can improve productivity and teamwork, and we make it simple for users to save and share their findings with others. We want to make information more accessible and easier to find and to empower people to do their job more effectively.

UBIQ Aerospace was founded in late 2017, with the mission of providing enabling technologies to unmanned and autonomous aircraft. We aspire to hire great people that immerse themselves into key issues and obstacles experienced in the industry and through dedicated processes, with stakeholders, to design and develop solutions that bring great value to our customers and the industry. The first tech. is the proprietary D•ICE technology, an autonomous icing protection solution for unmanned aircraft. The D•ICE tech is the only autonomous icing protection solution available. With its dedicated icing detection algorithms and intelligent control algorithms, D•ICE requires no third-party sensors and no human-interaction.

Norselab is Norway’s leading growth fund for meaningful technology companies; industrial technology startups and scaleups with an ambition to create a net positive impact for people and the planet. The team behind Norselab are seasoned entrepreneurs with a high level of expertise in scaling and growing technology ventures. Through a high degree of involvement with portfolio companies, Norselab aims to propel more Norwegian technology companies toward international success and help ignite change in traditional industries. Read more at norselab.com

Dyrkbart tilbyr komposterings- og dyrkingstenester til næringslivet og nabolaget. Dyrkbart si historie starta med prosjektet Kompostringen i 2020. Kompostringen blei til hos Lystgården på Landås etter initiativ frå Bybonden i Bergen. Dyrkbart AS blei stifta året etter for å drifte Kompostringen vidare. I dag står Stiftelsen Lystgården og Anleggsgartnermester Wikholm som eigarar, og Dyrkbart har kontor hos VIS Innovasjon på Marineholmen.

Nutcracker Solutions owns the product StadiaPitch by Bosch Rexroth and have licensed it to Bosch Rexroth until 2038.  The product is sold worldwide by the Bosch Corporation, and Nutcracker is a part of Bosch`s International StadiaPItch sales team. The goal is to reach 4 sales a year. Bosch pays Nutcracker a license fee between €1M - €1.5M per sale. 90% of the fee is due 5 months after Bosch has signed the contract with the stadium. Nutcracker has a flat predictable annual operating cost of €0.4M, regardless of how many StadiaPitch Sales Bosch Rexroth has in that year.  StadiaPitch entered the commercial phase in 2018 and has received an overwhelming market response. StadiaPitch is today included in the architectural drawings on three stadium projects, and Bosch has solid interest from several of the largest clubs in the world. StadiaPitch has received interest from architects, stadiums, and other stakeholders from 25 countries in the last 12 months.  Nutcracker is a dividend stock and the company is priced at 40 MNOK – pre-money. Nutcracker runs a Private Placement of 1OMNOK through a share issue that will equal to 20% of the new total number of shares. This funding will be spent on IPR, activities that enhance Bosch`s global sales work, and operating costs until we get income from the first Bosch contract. We pay a preference dividend equivalent to 50% of the investment for new investors. We have a commitment of 9 MNOK and we close the placement when we reach after the NXT 2019 events.

Waste management solutions. Primary machines and equipment, but also consulting. We make a profit by helping customers reduce their costs (and even make a profit). Enterprises can save/make money by focusing on the environment.  Both parties win. Eco-Nor Group may consider investors to cooperate with good and long-term partners as a matter of urgency.

Oncoinvent AS is a privately held Norwegian company established in 2010. The company is committed to developing new innovative products to provide better treatment options to cancer patients. The innovations being developed by Oncoinvent AS are a result of the extensive experience with the development of radionuclide-based cancer treatments of two of the founders, Dr. Roy H. Larsen and Professor of clinical oncology Øyvind S. Bruland. Larsen and Bruland are the inventors of the first FDA and EMA-approved alpha-emitting pharmaceutical product Xofigo® (Bayer AG), as well as of the beta-emitting radio-immunotherapeutic product candidate Betalutin® (Nordic Nanovector ASA). Oncoinvent's lead product candidate, Radspherin®, is a novel alpha-emitting radioactive microsphere designed for the treatment of metastatic cancers in body cavities. Radspherin® has been shown to cause a significant reduction in tumor cell growth. It is anticipated that the product can potentially treat several forms of metastatic cancer. The first clinical indication for Radspherin® will be the treatment of peritoneal carcinomatosis. Clinical development will be conducted in collaboration with European and American clinical research centers.

OncoImmunity is a bioinformatics company providing unique machine-learning software to identify tumor-specific mutations that can be targeted by a patient’s own immune system (known as neoantigens). The OncoImmunity solution is important because recent breakthroughs in the field of Immuno-Oncology (I-O) such as the development of checkpoint inhibitors and personalized cancer vaccines, clearly demonstrate that a patient’s immune system can be harnessed to successfully treat cancer. The cost of identifying tumor-specific mutations in a patient’s cancer using next-generation sequencing (NGS) is now trivial and this technology will be key to enabling truly personalized immunotherapies to be developed in a technically and economically feasible manner. However, the remaining challenge that currently limits the field, and which is addressed by the OncoImmunity solution, is predicting which tumor-specific mutations can stimulate a patient’s immune system i.e. are immunogenic. Using NGS data as input, the OncoImmunity software enables accurate patient selection for cancer immunotherapy and can identify optimal targets for personalized cancer vaccines & cell therapies in a clinically actionable time frame. Beginning from this first product offering, OncoImmunity has the vision to become the world’s leading provider of software to guide cancer immunotherapy to improve survival rates for cancer patients. To achieve this OncoImmunity has assembled a growing team of world-class bioinformaticians, data scientists, and software engineers; developing its cutting-edge machine-learning technology that will help fulfill the promise of immunotherapy in the fight against cancer. OncoImmunity’s technology will disrupt the I-O field by offering regulatory-compliant prediction software on a software-as-a-service basis (SaaS). This will allow big pharma, biotechnology, and immunotherapy companies of any size to access OncoImmunity’s cutting-edge prediction software. The company is headquartered in an ideal scientific and entrepreneurial ecosystem to develop its technology at the Oslo Cancer Cluster Incubator; adjacent to the Institute for Cancer Research and the Norwegian Radium Hospital. OncoImmunity is a privately held company, founded in 2014 by experienced bioinformatics scientists (Dr. Trevor Clancy and Professor Eivind Hovig), and an experienced immunologist with a business development background (Dr. Richard Stratford). The company is backed by private financing from the Norwegian Radium Hospital Research Foundation, the Norwegian Cancer Society, STARTUPLAB, and Grotmol Solutions, in addition to a number of private software investors. The company is also supported by grants awarded from the Norwegian Research Council, Innovation Norway, and the EU. The company has already established both national and international collaborations and pilot projects to develop further proof-of-concept data and validate its software.

Together with four Norwegian hospitals, we have developed the next generation hospital bed. A bed that prevents pressure ulcers, fall and reduce nurse load by removing heavy lifting and monitors the patients state, non intrusive. Have recieved contracts in Toronto that accelerates development, and secures uptake and sales if the clinical trial goes as planned.

Our mission is to create a thriving and evolving community of startups and creatives.DIGS is an innovation platform located in Trondheim, built on exchanges between members and partners who unite entrepreneurs, ‘makers’, and ‘doers’ from varied sectors. DIGS supports startup activities by providing an office environment and space for public activities, stimulating a culture of collaboration, sustainability, and mutual innovation through shared knowledge and experience. We participate in entrepreneurship networks across Norway, Europe, and internationally and aim to strengthen ties, stimulate the local community, and boost business development in and around the region of Trondheim. The idea of creating DIGS started with three enthusiastic people who wanted to make space for innovation in Trondheim. They started working on the idea in 2011 and acquired the space we are currently located in in the summer of 2013. The word DIGS means workplace and living space.

Pixotope Technologies is an international, award-winning technology and service company headquartered in Norway. Our flagship product Pixotope® is the world’s leading mixed reality solution for media production that allows media producers and content creators to produce exciting mixed reality content for television, online streaming, and film. Our product and services have been used in some of the largest live productions made in the last few years, such as the Superbowl, League of Legends Championship broadcasts, Euro-vision, and The Weather Channels mixed reality experiences. A selection of these productions can be viewed on our website: https://www.pixotope.com/customers We are a global company with headquarters in Oslo and branch offices in Los Angeles, London, Madrid, and Zagreb. Our customers are from every corner of the world.

OK, Self-Storage Group consists of the brand's City Self-Storage and OK Minilager. We have more than 60 locations in Scandinavia. We aspire to be the leading company in tech in our industry. We have just closed funding from several investors, and we have an ambitious growth plan for the years to come.

Garden is a development automation platform for Kubernetes and cloud native applications. The widespread adoption of cloud native technologies such as containers and Kubernetes has made it easier than ever to operate and scale applications. But important developer workflows have been overlooked or neglected along the way. Many developers find that they’re now less productive than they were before the cloud native era. Developers working on distributed microservices applications have been left without an efficient way to build, run tests, and iterate in a production-like environment. Garden makes it easy to spin up production-like environments for development, testing, and CI, and to use the same workflows for every stage of the process. With Garden, developers get fast feedback exactly when they need it, and DevOps teams are no longer bogged down with provisioning and managing ad hoc environments.

At Hintly we're on a mission to help sales teams target the right customers, thus helping good companies succeed and creating more relevance in the market. We've spent years building a killer product that is now proven with international customers, and we're ready to take over the world 🚀 Hintly is a Copenhagen-based SaaS tool that helps sales teams identify the best prospects in the market (the needles in the haystack). The solution utilises mountains of data and machine learning to generate an intelligent lead score based on +600 data fields. Our customers experience: 🎯 Tremendoust boost in conversion rates (e.g. meetings booked) 📈 Increase in sales rep efficiency 🕵‍♂️ Identifying great customers outside their original scope